DAFNA Capital Management’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-312,119
| Closed | -$8.93M | – | 88 |
|
|
2018
Q4 | $8.93M | Buy |
312,119
+6,000
| +2% | +$170K | 4.44% | 5 |
|
|
2018
Q3 | $8.54M | Hold |
306,119
| – | – | 3.51% | 5 |
|
|
2018
Q2 | $8.54M | Hold |
306,119
| – | – | 4% | 5 |
|
|
2018
Q1 | $7.61M | Buy |
306,119
+90,000
| +42% | +$2.19M | 3.7% | 6 |
|
|
2017
Q4 | $5.24M | Hold |
216,119
| – | – | 2.82% | 9 |
|
|
2017
Q3 | $5.96M | Hold |
216,119
| – | – | 3.7% | 6 |
|
|
2017
Q2 | $5.42M | Hold |
216,119
| – | – | 3.87% | 5 |
|
|
2017
Q1 | $5.8M | Sell |
216,119
-20,000
| -8% | -$552K | 4.9% | 3 |
|
|
2016
Q4 | $6.19M | Sell |
236,119
-2,390
| -1% | -$59.1K | 5.44% | 2 |
|
|
2016
Q3 | $5.96M | Sell |
238,509
-118,000
| -33% | -$2.75M | 4.15% | 4 |
|
|
2016
Q2 | $7.73M | Sell |
356,509
-40,045
| -10% | -$714K | 6.13% | 1 |
|
|
2016
Q1 | $5.94M | Buy |
396,554
+30,000
| +8% | +$503K | 5.13% | 3 |
|
|
2015
Q4 | $8.03M | Hold |
366,554
| – | – | 7.16% | 2 |
|
|
2015
Q3 | $5.78M | Hold |
366,554
| – | – | 5.74% | 3 |
|
|
2015
Q2 | $5.24M | Hold |
366,554
| – | – | 4.43% | 3 |
|
|
2015
Q1 | $6.34M | Sell |
366,554
-17,600
| -5% | -$311K | 4.87% | 4 |
|
|
2014
Q4 | $6.89M | Hold |
384,154
| – | – | 5.45% | 4 |
|
|
2014
Q3 | $5.04M | Hold |
384,154
| – | – | 5.09% | 4 |
|
|
2014
Q2 | $5.52M | Hold |
384,154
| – | – | 5.23% | 5 |
|
|
2014
Q1 | $4.89M | Hold |
384,154
| – | – | 4.21% | 9 |
|
|
2013
Q4 | $3.84M | Buy |
384,154
+132,500
| +53% | +$1.5M | 3.95% | 10 |
|
|
2013
Q3 | $3.31M | Hold |
251,654
| – | – | 3.62% | 9 |
|
|
2013
Q2 | $3.59M | Buy |
+251,654
| New | +$3.16M | 5.26% | 7 |
|
Other funds holding NXTM
DAFNA Capital Management's NXTM Position: Q1 2019 in Review
DAFNA Capital Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 312,119 shares — an estimated $8.93M sold.
DAFNA Capital Management first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $8.93M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- DAFNA Capital Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- DAFNA Capital Management sold 312,119 NxStage Medical Inc. shares in Q1 2019, an estimated $8.93M.
- DAFNA Capital Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- DAFNA Capital Management's NxStage Medical Inc. position peaked at $8.93M in Q4 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on DAFNA Capital Management's 13F filing for Q1 2019, filed 15 May 2019.